Email address
[email protected]Contact number
+61 2 9291 6100Provided by Maddocks
Maddocks is one of few Australian law firms with a true sector focus in the life sciences.
We have a particular reputation in the market for advising clients on product launch and litigation strategies in complex patent landscapes, particularly in the life sciences, biosimilars, pharmaceuticals and medical devices space. We are also known for advising on some of the largest M&A and commercialisation transactions in the sector.
With market leading Healthcare, Corporate M&A, IP and TMT practices, our strategy involves bringing together IP, life sciences and health regulatory experience with corporate M&A and technical TMT expertise to collaboratively solve the challenges our life sciences and healthcare clients are increasingly facing in transforming their business models to realise the opportunities in areas such as digital health, rapid diagnostics, biosimilars, health data management and privacy, personalised medicine, radiopharmaceuticals and clinical genomics.
Provided by Chambers
Maddocks houses a strong team of life sciences practitioners who are frequently called upon to act for generic and biosimilar companies in proceedings on patent revocations and oppositions. The team also has expertise in the drafting and negotiation of licence agreements and R&D collaboration agreements. The firm is adept at handling investment and M&A transactions.
Provided by Maddocks
Maddocks acted for Cipla in proceedings to revoke two of BMS and Pfizer’s patents relating to apixaban, an anticoagulant drug marketed as ELIQUIS.
Provided by Chambers
Maddocks is very experienced in what it does and is very easy to work with.
Maddocks is very experienced in what it does and is very easy to work with.
Provided by Chambers
Ben's advice is clear, crisp and comprehensive, which is helpful especially for decision-makers in our company.
Ben makes us feel that we are the biggest client.